Skip to main content
. 2018 Apr 4;23(4):826. doi: 10.3390/molecules23040826

Figure 2.

Figure 2

(a) Schematic illustration of composition/structure of the HA-Hybrid NPs, and its binding to CD44 on breast cancer stem cells (bCSCs); (b) The cell viability of MCF7 mammosphere cells after treated with different drug formulations at varying concentration for 48 h; (c) the relative volume of the mammosphere at the end of treatment (volume normalized to that at 0 day); (d) the tumor weight at the experimental end point (20th day); reproduced with the permission from [75], Copyright (2017) The Royal Society of Chemistry.